IL6 and infection: Despite these results, the 20% concentration was maintained for both the viability assay on infected cells and the IL-6 ELISA experiments, as the presence of bacterial pathogens capable of metabolizing certain CFS components could still yield beneficial effects in preventing infection outcomes.